ClinConnect ClinConnect Logo
Search / Trial NCT06891261

One Stage Ridge Splitting Using 2 Different Techniques in Maxilla

Launched by CAIRO UNIVERSITY · Mar 17, 2025

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Ridge Augmentation One Stage Ridge Splitting In Maxilla. Piezo Surgery

ClinConnect Summary

This clinical trial is investigating two different techniques for a procedure called ridge splitting in the upper jaw (maxilla) to help patients who need bone augmentation. The goal is to improve the area where teeth are missing to prepare for dental implants. Participants will receive local anesthesia to ensure comfort during the procedure, which involves making a flap in the gum, assessing the bone condition, and using different tools to create space for the implants. One group will use piezo surgery, a gentle method to cut the bone, while the other will use traditional bone discs. After the procedure, a special type of bone material will be placed to support healing.

To be eligible for this trial, participants should have enough bone height (at least 8 mm) and width (between 3 mm and 5 mm) in the jaw, be missing at least one tooth, and may have previously experienced implant failures. Certain factors, such as smoking heavily, having specific medical conditions, or being under 18, will exclude individuals from participating. Participants can expect thorough evaluations and follow-up imaging after four months to assess the results of the procedure. Overall, this study aims to find the best approach to help patients regain their dental function and improve their smiles.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with maxilla residual alveolar bone height not less than 8 mm.
  • Alveolar bone width from 5mm to 3mm.
  • Both genders.
  • At least single missing tooth.
  • Previous failed implants.
  • Tapered or cylinder cross sectioned alveolar bone defect pattern.
  • Exclusion Criteria:
  • Heavy smokers more than 20 cigarettes per day.
  • Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
  • Patients had radiotherapy and chemotherapy in head and neck.
  • Patients had neoplasms in sites to be grafted.
  • Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.
  • Pregnant females.
  • Patients with Para functional habits, apprehensive and non-cooperative.
  • Bone pathology related to the site to be grafted.
  • Psychological problems, stress situation (socially or professionally), emotional instability, and unrealistic patients' expectations.
  • Intraoral soft and hard tissue pathology.
  • Systemic condition that contraindicates implant placement.
  • Under the age of 18 years.
  • Hourglass defects or defects with bone concavities and or undercuts.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported